Literature DB >> 8799231

Assessment of reperfusion after acute myocardial infarction: is there a role for acute technetium 99m-teboroxime imaging?

A J Sinusas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8799231     DOI： 10.1016/s1071-3581(96)90027-6

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  28 in total

1.  Present status of rescue coronary angioplasty: current polarization of opinion and randomized trials.

Authors:  S G Ellis; F Van de Werf; E Ribeiro-daSilva; E J Topol
Journal:  J Am Coll Cardiol       Date:  1992-03-01       Impact factor: 24.094

2.  Myocardial clearance kinetics of technetium-99m-SQ30217: a marker of regional myocardial blood flow.

Authors:  R E Stewart; M Schwaiger; G D Hutchins; P C Chiao; K P Gallagher; N Nguyen; N A Petry; W L Rogers
Journal:  J Nucl Med       Date:  1990-07       Impact factor: 10.057

3.  Uptake and release of two new Tc-99m labeled myocardial blood flow imaging agents in cultured cardiac cells.

Authors:  J C Maublant; N Moins; P Gachon
Journal:  Eur J Nucl Med       Date:  1989

4.  Premortem assessment of myocardial area at risk with the use of intracoronary technetium macroaggregated albumin and gated nuclear imaging.

Authors:  A J Feiring; P Bruch; T S Husayni; P T Kirchner; M L Marcus
Journal:  Circulation       Date:  1986-03       Impact factor: 29.690

5.  Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction.

Authors:  R J Gibbons; M S Verani; T Behrenbeck; P A Pellikka; M K O'Connor; J J Mahmarian; J H Chesebro; F J Wackers
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

6.  Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups.

Authors:  R J Gibbons; D R Holmes; G S Reeder; K R Bailey; M R Hopfenspirger; B J Gersh
Journal:  N Engl J Med       Date:  1993-03-11       Impact factor: 91.245

7.  Use of sequential teboroxime imaging for the detection of coronary artery occlusion and reperfusion in ischemic and infarcted myocardium.

Authors:  L I Heller; B J Villegas; B H Weiner; B A McSherry; S T Dahlberg; J A Leppo
Journal:  Am Heart J       Date:  1994-04       Impact factor: 4.749

8.  Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial.

Authors:  F J Wackers; M L Terrin; D S Kayden; G Knatterud; S Forman; E Braunwald; B L Zaret
Journal:  J Am Coll Cardiol       Date:  1989-04       Impact factor: 24.094

9.  Coronary thrombolysis and myocardial salvage by tissue plasminogen activator given up to 4 hours after onset of myocardial infarction. National Heart Foundation of Australia Coronary Thrombolysis Group.

Authors: 
Journal:  Lancet       Date:  1988-01-30       Impact factor: 79.321

10.  Teboroxime is a marker of reperfusion after myocardial infarction.

Authors:  L I Heller; B J Villegas; C P Reinhardt; S T Dahlberg; R Marcel; J A Leppo
Journal:  J Nucl Cardiol       Date:  1996 Jan-Feb       Impact factor: 5.952
View more
  1 in total

1.  A fast cardiac gamma camera with dynamic SPECT capabilities: design, system validation and future potential.

Authors:  Moshe Bocher; Ira M Blevis; Leonid Tsukerman; Yigal Shrem; Gil Kovalski; Lana Volokh
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06-29       Impact factor: 9.236
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.